Xenon Pharmaceuticals (XENE) Earnings (2013 - 2026)
Xenon Pharmaceuticals (XENE) earnings from Sep 30, 2013 to Mar 31, 2026. The TTM Xenon Pharmaceuticals (XENE) earnings is -$383M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Xenon Pharmaceuticals (XENE) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +52.39% |
| 3 Years TTM | +37.49% |
| 5 Years TTM | +72.93% |
| 10 Years TTM | +51.74% |
Annual Earnings change of Xenon Pharmaceuticals (XENE)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$102M | -70.43% |
| 2025 | -$346M | +47.62% |
| 2024 | -$234M | +28.48% |
| 2023 | -$182M | +45.48% |
| 2022 | -$125M | +58.94% |
| 2021 | -$79M | +173.51% |
| 2020 | -$29M | -30.66% |
| 2019 | -$42M | +20.55% |
| 2018 | -$35M | +12.38% |
| 2017 | -$31M | +33.48% |
| 2016 | -$23M | +46.03% |
| 2015 | -$16M | -220.97% |
| 2014 | $13M | +8.23% |
| 2013 | $12M | -379.77% |
| 2012 | -$4.30M | N/A |
Comparison Xenon Pharmaceuticals (XENE) five years earnings CAGR with competitors
Xenon Pharmaceuticals (XENE) five years earnings CAGR is 64.02%.